Toshifumi Nomura Selected Research

Chemokines

1/2024	Possible correlation between serum interleukin-8 levels and the activity of myositis in anti-NXP2 antibody-positive dermatomyositis.
4/2017	Altered balance of epidermis-related chemokines in epidermolysis bullosa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toshifumi Nomura Research Topics

Disease

9	Atopic Dermatitis (Atopic Eczema) 01/2023 - 02/2007
6	Dermatomyositis (Dermatopolymyositis) 01/2024 - 10/2021
4	Bullous Pemphigoid (Pemphigoid) 02/2024 - 01/2019
4	Myositis (Idiopathic Inflammatory Myopathies) 01/2024 - 01/2022
4	Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris) 07/2014 - 02/2007
3	Neoplasms (Cancer) 01/2024 - 01/2022
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 01/2022
3	Ichthyosis (Xeroderma) 03/2023 - 01/2019
3	Asthma (Bronchial Asthma) 05/2022 - 12/2010
3	Inborn Genetic Diseases (Disease, Hereditary) 01/2021 - 01/2018
3	Epidermolysis Bullosa 01/2021 - 10/2016
2	Melanoma (Melanoma, Malignant) 05/2024 - 10/2023
2	Pemphigus (Pemphigus Vulgaris) 04/2024 - 03/2012
2	Infections 11/2023 - 08/2018
2	Radiodermatitis 11/2023 - 09/2023
2	Epidermolytic Hyperkeratosis (Bullous Congenital Ichthyosiform Erythroderma) 03/2023 - 07/2008
2	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2022 - 04/2016
2	Cutaneous Lupus Erythematosus 05/2022 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 09/2007
2	Pruritus (Itching) 01/2022 - 07/2012
2	Epidermolysis Bullosa Dystrophica (Dystrophic Epidermolysis Bullosa) 01/2019 - 11/2012
2	Eczema 12/2018 - 03/2009
2	Palmoplantar Keratoderma (Keratosis Palmaris et Plantaris) 09/2015 - 01/2015
1	Acute Lung Injury 04/2024
1	Virus Diseases (Viral Diseases) 04/2024
1	Inflammation (Inflammations) 04/2024
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 12/2023
1	COVID-19 11/2023
1	Acneiform Eruptions 07/2023
1	Contact Dermatitis (Eczema, Contact) 04/2023
1	Mycosis Fungoides 01/2023
1	Pain (Aches) 01/2023
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023
1	Exfoliative Dermatitis (Erythroderma) 01/2023
1	Dermatitis 12/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 05/2022
1	Arthralgia (Joint Pain) 05/2022
1	Diffuse alopecia 05/2022
1	Carcinogenesis 01/2022
1	Disease Progression 01/2022
1	Exanthema (Rash) 01/2022
1	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022
1	Diarrhea 01/2022
1	Muscular Diseases (Myopathy) 01/2022
1	Hidradenitis Suppurativa 01/2022
1	Contracture 01/2022
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Calcinosis 01/2022
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022

Drug/Important Bio-Agent (IBA)

9	Filaggrin ProteinsIBA 08/2020 - 02/2007
4	Proteins (Proteins, Gene)FDA Link 11/2023 - 01/2018
3	nuclear matrix protein 2IBA 01/2024 - 01/2022
3	AutoantibodiesIBA 11/2023 - 01/2022
3	loricrinIBA 01/2022 - 01/2019
2	AntibodiesIBA 02/2024 - 05/2022
2	Immunoglobulin G (IgG)IBA 02/2024 - 01/2023
2	CytokinesIBA 01/2024 - 03/2023
2	ChemokinesIBA 01/2024 - 04/2017
2	eribulin FDA Link 11/2023 - 01/2023
2	Interleukin-18 (Interleukin 18)IBA 03/2023 - 07/2012
2	AntigensIBA 01/2023 - 05/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2022
2	apremilastIBA 01/2022 - 01/2022
2	Ligases (Synthetase)IBA 11/2021 - 10/2021
2	Mutant Proteins (Protein, Mutant)IBA 01/2021 - 02/2020
2	Etretinate FDA Link 09/2015 - 01/2015
1	Toll-Like Receptor 7IBA 04/2024
1	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2024
1	Poly I-CIBA 04/2024
1	EnzymesIBA 01/2024
1	Interleukin-8 (Interleukin 8)IBA 01/2024
1	ImmunosorbentsIBA 01/2024
1	DystrophinIBA 12/2023
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2023
1	HydrazinesIBA 12/2023
1	DipeptidesIBA 12/2023
1	negamycinIBA 12/2023
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2023
1	BromidesIBA 07/2023
1	olanexidine gluconateIBA 04/2023
1	Disinfectants (Biocides)IBA 04/2023
1	Brentuximab VedotinIBA 01/2023
1	enfortumab vedotinIBA 01/2023
1	halichondrin BIBA 01/2023
1	Cadherins (E-Cadherin)IBA 01/2023
1	Imiquimod (Aldara)FDA LinkGeneric 12/2022
1	dupilumabIBA 05/2022
1	Interleukin-13IBA 05/2022
1	InterleukinsIBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	RibonucleoproteinsIBA 05/2022
1	DNA (Deoxyribonucleic Acid)IBA 05/2022
1	SteroidsIBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	Phosphodiesterase 4 InhibitorsIBA 01/2022
1	Adalimumab (Humira)FDA Link 01/2022

Therapy/Procedure

3	Therapeutics 01/2021 - 01/2019
1	Surgical Amputation (Amputations) 05/2024
1	Intranasal Administration 04/2024
1	Radiotherapy 09/2023